Onasemnogene abeparvovec gene therapy in presymptomatic spinal muscular atrophy (SMA): SPR1NT study update

被引:1
|
作者
Strauss, K. [1 ]
Farrar, M. [2 ]
Swoboda, K. [3 ]
Saito, K. [4 ]
Chiriboga, C. [5 ]
Finkel, R. [6 ]
Iannaccone, S. [7 ]
Krueger, J. [8 ]
Kwon, J. [9 ]
McMillan, H. [10 ]
Servais, L. [11 ]
Mendell, J. [12 ]
Parsons, J. [13 ]
Scoto, M. [14 ]
Shieh, P. [15 ]
Zaidman, C. [16 ]
Schultz, M. [17 ]
Ogrinc, F. [17 ]
Group, S.
Muntoni, F. [14 ]
机构
[1] Childrens Hosp Pittsburgh, Strasburg, PA USA
[2] Sydney Childrens Hosp, Randwick, NSW, Australia
[3] MA Gen Hosp Children, Boston, MA USA
[4] TWMU, Tokyo, Japan
[5] Columbia Med Ctr, New York, NY USA
[6] St Jude Childrens Res Hosp, Memphis, TN USA
[7] Southwestern Med Ctr, Dallas, TX USA
[8] Helen DeVos Childrens Hosp, Grand Rapids, MI USA
[9] Univ Wisconsin, Madison, WI 53706 USA
[10] CHEO, Ottawa, ON, Canada
[11] MDUK Oxford Neuromuscular Ctr, Oxford, England
[12] Nationwide Childrens Hosp, Columbus, OH USA
[13] Univ Colorado, Aurora, CO USA
[14] Great Ormond St Hosp Sick Children, London, England
[15] Univ Calif Los Angeles, Los Angeles, CA USA
[16] Washington Univ, St Louis, MO 63110 USA
[17] AveXis Inc, Bannockburn, IL USA
关键词
D O I
10.1016/j.nmd.2020.08.259
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.260
引用
收藏
页码:S122 / S122
页数:1
相关论文
共 50 条
  • [1] Onasemnogene Abeparvovec-xioi Gene Therapy in Presymptomatic Spinal Muscular Atrophy (SMA): SPR1NT Study Update
    Strauss, K. A.
    Farrar, M. A.
    Swoboda, K. J.
    Saito, K.
    Chiriboga, C. A.
    Finkel, R. S.
    Iannaccone, S. T.
    Krueger, J. M.
    Kwon, J. M.
    McMillan, H. J.
    Servais, L.
    Mendell, J. R.
    Parsons, J.
    Scoto, M.
    Shieh, P. B.
    Zaidman, C.
    Schultz, M.
    Baldinetti, F.
    Ogrinc, F. G.
    Kavanagh, S.
    Feltner, D. E.
    Tauscher-Wisniewski, S.
    McGill, B. E.
    Sproule, D. M.
    Muntoni, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 165 - 166
  • [2] Onasemnogene abeparvovec gene-replacement therapy (GRT) in presymptomatic spinal muscular atrophy (SMA): SPR1NT study update
    Strauss, K. A.
    Swoboda, K. J.
    Farrar, M. A.
    McMillan, H. J.
    Parsons, J.
    Krueger, J. M.
    Iannaccone, S. T.
    Chiriboga, C. A.
    Kwon, J. M.
    Saito, K.
    Scoto, M.
    Baldinetti, F.
    Schultz, M.
    Kernbauer, E.
    Farrow, M.
    Ogrinc, F. G.
    Kavanagh, S.
    Feltner, D. E.
    McGill, B. E.
    Spector, S. A.
    L'Italien, J.
    Sproule, D. M.
    Muntoni, F.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [3] ONASEMNOGENE ABEPARVOVEC-XIOI GENE-REPLACEMENT THERAPY IN PRESYMPTOMATIC SPINAL MUSCULAR ATROPHY (SMA): SPR1NT STUDY UPDATE
    Strauss, Kevin A.
    Swoboda, Kathryn J.
    Farrar, Michelle A.
    McMillan, Hugh J.
    Parsons, Julie
    Krueger, Jena M.
    Iannaccone, Susan T.
    Chiriboga, Claudia A.
    Kwon, Jennifer M.
    Saito, Kayoko
    Scoto, Mariacristina
    Schultz, Meredith
    Kernbauer, Elaine
    Farrow, Marcia
    Ogrinc, Francis G.
    Kavanagh, Sarah
    Feltner, Douglas E.
    McGill, Bryan E.
    Meriggioli, Matthew
    L'ltalien, James
    Sproule, Douglas M.
    Muntoni, Francesco
    MUSCLE & NERVE, 2019, 60 : S13 - S13
  • [4] Onasemnogene Abeparvovec-xioi Gene-Replacement Therapy in Presymptomatic Spinal Muscular Atrophy: SPR1NT Study Update
    Strauss, Kevin A.
    Farrar, Michelle A.
    Swoboda, Kathryn J.
    Saito, Kayoko
    Chiriboga, Claudia A.
    Finkel, Richard S.
    Iannaccone, Susan T.
    Krueger, Jena M.
    Kwon, Jennifer M.
    McMillan, Hugh J.
    Servais, Laurent
    Mendell, Jerry R.
    Parsons, Julie
    Scoto, Mariacristina
    Shieh, Perry B.
    Zaidman, Craig
    Schultz, Meredith
    Kernbauer, Elaine
    Joshi, Shivani
    Ogrinc, Francis G.
    Kavanagh, Sarah
    Feltner, Douglas E.
    Tauscher-Wisniewski, Sitra
    McGill, Bryan E.
    Sproule, Douglas M.
    Muntoni, Francesco
    NEUROLOGY, 2020, 94 (15)
  • [5] Onasemnogene Abeparvovec Gene Therapy in Presymptomatic Spinal Muscular Atrophy (SMA): SPR1NT Study Update in Children with 3 Copies of SMN2
    Strauss, Kevin
    Muntoni, Francesco
    Farrar, Michelle
    Saito, Kayoko
    Mendell, Jerry
    Servais, Laurent
    McMillan, Hugh
    Swoboda, Kathryn
    Kwon, Jennifer
    Zaidman, Craig
    Chiriboga, Claudia
    Iannaccone, Susan
    Krueger, Jena
    Parsons, Julie
    Shieh, Perry
    Kavanagh, Sarah
    Chand, Deepa
    Tauscher-Wisniewski, Sitra
    Macek, Thomas
    NEUROLOGY, 2021, 96 (15)
  • [6] Onasemnogene Abeparvovec Gene Therapy in Presymptomatic Spinal Muscular Atrophy (SMA): SPR1NT Study Update in Children with 3 Copies of SMN2
    McMillan, H.
    Strauss, K.
    Muntoni, F.
    Farrar, M.
    Saito, K.
    Mendell, J.
    Servais, L.
    Swoboda, K.
    Kwon, J.
    Zaidman, C.
    Chiriboga, C.
    Iannaccone, S.
    Krueger, J.
    Parsons, J.
    ANNALS OF NEUROLOGY, 2021, 90 : S152 - S152
  • [7] Onasemnogene Abeparvovec Gene Therapy in Presymptomatic spinal muscular atrophy (SMA): SPR1NT study update in children with 3 Copies of SMN2
    Strauss, K.
    Muntoni, F.
    Farrar, M.
    Saito, K.
    Mendell, J.
    Servais, L.
    McMillan, H.
    Swoboda, K.
    Kwon, J.
    Zaidman, C.
    Chiriboga, C.
    Iannaccone, S.
    Krueger, J.
    Parsons, J.
    Shieh, P.
    Kavanagh, S.
    Chand, D.
    Tauscher-Wisniewski, S.
    Macek, T.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S133 - S133
  • [8] Onasemnogene abeparvovec preserves bulbar function in infants with presymptomatic spinal muscular atrophy: a post-hoc analysis of the SPR1NT trial
    Shell, Richard D.
    Mcgrattan, Katlyn E.
    Hurst-Davis, Rebecca
    Young, Sally Dunaway
    Baranello, Giovanni
    Lavrov, Arseniy
    O'Brien, Eamonn
    Wallach, Shiri
    Lamarca, Nicole
    Reyna, Sandra P.
    Darras, Basil T.
    NEUROMUSCULAR DISORDERS, 2023, 33 (08) : 670 - 676
  • [9] Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
    Kevin A. Strauss
    Michelle A. Farrar
    Francesco Muntoni
    Kayoko Saito
    Jerry R. Mendell
    Laurent Servais
    Hugh J. McMillan
    Richard S. Finkel
    Kathryn J. Swoboda
    Jennifer M. Kwon
    Craig M. Zaidman
    Claudia A. Chiriboga
    Susan T. Iannaccone
    Jena M. Krueger
    Julie A. Parsons
    Perry B. Shieh
    Sarah Kavanagh
    Melissa Wigderson
    Sitra Tauscher-Wisniewski
    Bryan E. McGill
    Thomas A. Macek
    Nature Medicine, 2022, 28 : 1390 - 1397
  • [10] Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
    Strauss, Kevin A.
    Farrar, Michelle A.
    Muntoni, Francesco
    Saito, Kayoko
    Mendell, Jerry R.
    Servais, Laurent
    McMillan, Hugh J.
    Finkel, Richard S.
    Swoboda, Kathryn J.
    Kwon, Jennifer M.
    Zaidman, Craig M.
    Chiriboga, Claudia A.
    Iannaccone, Susan T.
    Krueger, Jena M.
    Parsons, Julie A.
    Shieh, Perry B.
    Kavanagh, Sarah
    Wigderson, Melissa
    Tauscher-Wisniewski, Sitra
    McGill, Bryan E.
    Macek, Thomas A.
    NATURE MEDICINE, 2022, 28 (07) : 1390 - +